Evidence map›Paper›PMID 32795368›Full record

ArticleAIDS research and therapy2020

Cytomegalovirus and disseminated histoplasmosis-related hemophagocytic lymphohistiocytosis syndrome in an HIV-patient late presenter with IRIS: a case report.

Luz A González-Hernández, Monserrat Alvarez-Zavala, Rodolfo I Cabrera-Silva, Pedro Martínez-Ayala, Fernando Amador-Lara, Aída S Ramírez-González, Ana L Ron-Magaña, Vida V Ruiz Herrera, Karina Sánchez-Reyes, Jaime F Andrade-Villanueva

Open access · goldAbstract readCase Reports
In one paragraph

Article in AIDS research and therapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Luz A González-HernándezHIV Unit, Antiguo Hospital Civil de Guadalajara "Fray Antonio Alcalde", Guadalajara, Jalisco, Mexico.
Monserrat Alvarez-ZavalaHIV and Immunodeficiencies Research Institute, CUCS-University of Guadalajara, Guadalajara, Jalisco, Mexico.
Rodolfo I Cabrera-SilvaHIV and Immunodeficiencies Research Institute, CUCS-University of Guadalajara, Guadalajara, Jalisco, Mexico.
Pedro Martínez-AyalaHIV Unit, Antiguo Hospital Civil de Guadalajara "Fray Antonio Alcalde", Guadalajara, Jalisco, Mexico.
Fernando Amador-LaraHIV Unit, Antiguo Hospital Civil de Guadalajara "Fray Antonio Alcalde", Guadalajara, Jalisco, Mexico.
Aída S Ramírez-GonzálezHIV Unit, Antiguo Hospital Civil de Guadalajara "Fray Antonio Alcalde", Guadalajara, Jalisco, Mexico.
Ana L Ron-MagañaHematology and Trasplant Unit, Hospital Civil de Guadalajara "Fray Antonio Alcalde", Guadalajara, Jalisco, Mexico.
Vida V Ruiz HerreraHIV Unit, Antiguo Hospital Civil de Guadalajara "Fray Antonio Alcalde", Guadalajara, Jalisco, Mexico.
Karina Sánchez-ReyesHIV and Immunodeficiencies Research Institute, CUCS-University of Guadalajara, Guadalajara, Jalisco, Mexico. karina_reyesqfb@hotmail.com.
Jaime F Andrade-VillanuevaHIV Unit, Antiguo Hospital Civil de Guadalajara "Fray Antonio Alcalde", Guadalajara, Jalisco, Mexico. drjandradev@gmail.com.
Hospital Civil de Guadalajara · MXUniversidad de Guadalajara · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHemophagocytic lymphohistiocytosis syndrome (HLS) is an immune-mediated life-threatening disease considered as a medical emergency, with a potentially fatal multisystem inflammatory outcome. We present a patient that developed HLS and was able to be diagnosed efficiently with the help of an academic research institute of immunology. CASE PRESENTATION: A 21 years old male Mexican with human immunodeficiency virus (HIV), late presenter; who developed cytomegalovirus (CMV) infection and a disseminated histoplasmosis-related HLS, as part of an immune reconstitution inflammatory syndrome (IRIS). The patient required a long course of corticotherapy, intravenous immunoglobulin and massive transfusions (more than 10 units in 24 h, and a total of 83 units), besides amphotericin-B and ganciclovir treatment. An academic research institute of immunology aided in the accurate diagnosis of HLS with the implementation of tests not available within the hospital, thus improving the care provided to the patient. The patient recovered, was discharged, and continue to improve.

conclusionThe objective of this report is to highlight the importance of having multidisciplinary support, including basic medical sciences groups providing specific tests that are sometimes very difficult to get, which provides a benefit to patients in the well-aimed diagnosis as part of applied translational medicine.

Indexed as

Antiviral AgentsCytomegalovirus InfectionsHistoplasmosisHIV InfectionsHumansImmunoglobulins, IntravenousLymphohistiocytosis, HemophagocyticMaleTreatment OutcomeYoung AdultAntiviral AgentsImmunoglobulins, IntravenousApplied translational medicineCase reportCytomegalovirusDisseminated histoplasmosisHemophagocytic lymphohistiocytosis syndromeHIVIRIS

Identifiers

PMID32795368
PMCPMC7427876
OpenAlexW3049174401

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.